Respiratory Medicine
Volume 103, Issue 9 , Pages 1358-1365 , September 2009

Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers

  • Haibo Zhou

      Affiliations

    • The Center for Environmental Medicine, Asthma and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Department of Biostatistics, The Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Corresponding Author InformationCorresponding author at: Department of Biostatistics, CB# 7420 McGavran-Greenbery Hall, The Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7420, USA. Tel.: +1 919 966 3885; fax: +1 919 966 3804.
    • ,
  • Neil E. Alexis

      Affiliations

    • The Center for Environmental Medicine, Asthma and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Department of Pediatrics, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • Martha Almond

      Affiliations

    • The Center for Environmental Medicine, Asthma and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • James Donohue

      Affiliations

    • Department of Medicine, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • Craig LaForce

      Affiliations

    • Department of Pediatrics, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • North Carolina Clinical Research, Raleigh, NC, USA
    • ,
  • Philip A. Bromberg

      Affiliations

    • The Center for Environmental Medicine, Asthma and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Department of Medicine, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • David B. Peden

      Affiliations

    • The Center for Environmental Medicine, Asthma and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Department of Pediatrics, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • Department of Medicine, The School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Received 22 September 2008 ,Accepted 12 March 2009.

References 

  1. Vercelli D. Genetics, epigenetics, and the environment: switching, buffering, releasing. J Allergy Clin Immunol. 2004;113:381–386
  2. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol. 2002;270:109–120
  3. Brass DM, Hollingsworth JW, McElvania-Tekippe E, Garantzios S, Hossain I, Schwartz DA. CD14 is an essential mediator of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol. 2007;293:77–83
  4. Alexis N, Eldridge M, Reed W, Bromberg P, Peden DB. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol. 2001;107:31–35
  5. Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD.. Chest. 2003;123:1054–1059
  6. Regueiro V, Campos MA, Morey P, Sauleda J, Agustí AG, Garmendia J, et al. Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J. 2009 Feb;33(2):273–281
  7. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115:829–835
  8. Larsson L, Szponar B, Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air. 2004;14:421–424
  9. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759–764
  10. Martinez FD. Gene-environment interactions in asthma and allergies: a new paradigm to understand disease causation. Immunol Allergy Clin North Am. 2005;25:709–721
  11. LeVan TD, Von Essen S, Romberger DJ, Lambert GP, Martinez FD, Vasquez MM, et al. Polymorphisms in the CD14 gene associated with pulmonary function in farmers. Am J Respir Crit Care Med. 2005;171:773–779
  12. Palmer SM, Klimecki W, Yu L, Reinsmoen NL, Snyder LD, Ganous TM, et al. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant. 2007;7(3):693–699
  13. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20:976–983
  14. Keskin O, Birben E, Sackesen C, Soyer OU, Alyamac E, Karaaslan C, et al. The effect of CD14-c159 T genotypes on the cytokine response to endotoxin by peripheral blood mononuclear cells from asthmatic children. Ann Allergy Asthma Immunol. 2006;97:321–328
  15. Koppelman GH, Reijmerink NE, Colin SO, Howard TD, Whittaker PA, Meyers DA, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001;163:965–969
  16. Baldini M, Vercelli D, Martinez FD. CD14: an example of gene by environment interaction in allergic disease. Allergy. 2002;57:188–192
  17. Zambelli-Weiner A, Ehrlich E, Stockton ML, Grant AV, Zhang S, Levett PN, et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol. 2005;115:1203–1209
  18. Meyers DA, Postma DS, Stine OC, Koppelman GH, Ampleford EJ, Jongepier H, et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol. 2005;115:1169–1175
  19. Choudhry S, Avila PC, Nazario S, Ung N, Kho J, Rodriguez-Santana JR, et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am J Respir Crit Care Med. 2005;172:173–182
  20. Williams LK, McPhee RA, Ownby DR, Peterson EL, James M, Zoratti EM, et al. Gene-environment interactions with CD14 C-260 T and their relationship to total serum IgE levels in adults. J Allergy Clin Immunol. 2006;118:851–857
  21. Lodrup Carlsen KC, Lovik M, Granum B, Mowinckel P, Carlsen KH. Soluble CD14 at 2 yr of age: gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseases. Pediatr Allergy Immunol. 2006;17:304–312
  22. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and toll-like receptor 4: a link between infection and acute coronary events?. Heart. 2004;90:983–988
  23. Hohda S, Kimura A, Sasaoka T, Hayashi T, Ueda K, Yasunami M, et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J. 2003;44:613–622
  24. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999;99:3218–3220
  25. Amar J, Ruidavets JB, Bal dit SC, Bongard V, Boccalon H, Chamontin B, et al. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens. 2004;22:1523–1528
  26. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis. 1976;113:587–600
  27. Rosner B. Fundamentals of biostatistics. 6th ed.. Boston: Duxbury Press; 2006;
  28. SAS Institute . SAS/STAT user's guide, version 9.1. Cary, NC: SAS Institute; 2005;
  29. Alexis NE, Peden DB. Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14. J Allergy Clin Immunol. 2001;108:577–580
  30. Chhabra SK, Bhatnagar S. Comparison of bronchodilator responsiveness in asthma and chronic obstructive lung disease. Indian J Chest Dis Allied Sci. 2002;44:91–97
  31. Walker PP, Calverley PM. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. COPD. 2008;5:147–152
  32. O'Donnell DE, Forkert L, Webb L. Evaluation of bronchodilator response in patients with “irreversible” emphysema. Eur Respir J. 2001;18:914–920
  33. Schermer T, Heijdra Y, Zadal S, Van den Bemt L, Winter LB, Dekhuijzen R, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med. 2007;101:1355–1362
  34. Simpson A, John SL, Jury F, Niven R, Woodcock A, Ollier WE, et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med. 2006;174:386–392
  35. Jerrard-Dunne P, Sitzer M, Risley P, Buehler A, von Kegler S, Markus HS. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke. 2004;35:2438–2443
  36. Risley P, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2003;34:600–604

PII: S0954-6111(09)00091-2

doi: 10.1016/j.rmed.2009.03.007

Respiratory Medicine
Volume 103, Issue 9 , Pages 1358-1365 , September 2009

Article Tools

* Image Usage & Resolution